vs

Side-by-side financial comparison of HOVNANIAN ENTERPRISES INC (HOV) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $817.9M, roughly 1.8× HOVNANIAN ENTERPRISES INC). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -0.1%, a 4.5% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -16.5%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $164.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 17.3%).

Hovnanian Enterprises, Inc. is an American real estate company which is involved in every aspect of marketing homes, including design, construction and sales. The company works with individual detached housing as well as higher-occupancy dwellings, including townhouses, condominiums and retirement homes.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

HOV vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.8× larger
ONC
$1.5B
$817.9M
HOV
Growing faster (revenue YoY)
ONC
ONC
+49.3% gap
ONC
32.8%
-16.5%
HOV
Higher net margin
ONC
ONC
4.5% more per $
ONC
4.4%
-0.1%
HOV
More free cash flow
ONC
ONC
$215.8M more FCF
ONC
$379.8M
$164.0M
HOV
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
17.3%
HOV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HOV
HOV
ONC
ONC
Revenue
$817.9M
$1.5B
Net Profit
$-667.0K
$66.5M
Gross Margin
90.5%
Operating Margin
-0.5%
12.4%
Net Margin
-0.1%
4.4%
Revenue YoY
-16.5%
32.8%
Net Profit YoY
-100.7%
143.8%
EPS (diluted)
$-0.57
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HOV
HOV
ONC
ONC
Q4 25
$817.9M
$1.5B
Q3 25
$800.6M
$1.4B
Q2 25
$686.5M
$1.3B
Q1 25
$673.6M
$1.1B
Q4 24
$979.6M
$1.1B
Q3 24
$722.7M
$1.0B
Q2 24
$708.4M
$929.2M
Q1 24
$594.2M
$751.7M
Net Profit
HOV
HOV
ONC
ONC
Q4 25
$-667.0K
$66.5M
Q3 25
$16.6M
$124.8M
Q2 25
$19.7M
$94.3M
Q1 25
$28.2M
$1.3M
Q4 24
$94.3M
$-151.9M
Q3 24
$72.9M
$-121.3M
Q2 24
$50.8M
$-120.4M
Q1 24
$23.9M
$-251.2M
Gross Margin
HOV
HOV
ONC
ONC
Q4 25
90.5%
Q3 25
86.1%
Q2 25
87.5%
Q1 25
85.2%
Q4 24
85.8%
Q3 24
83.0%
Q2 24
85.1%
Q1 24
83.4%
Operating Margin
HOV
HOV
ONC
ONC
Q4 25
-0.5%
12.4%
Q3 25
3.0%
11.5%
Q2 25
3.9%
6.7%
Q1 25
5.9%
1.0%
Q4 24
12.0%
-7.0%
Q3 24
13.5%
-12.0%
Q2 24
9.8%
-11.5%
Q1 24
5.5%
-34.8%
Net Margin
HOV
HOV
ONC
ONC
Q4 25
-0.1%
4.4%
Q3 25
2.1%
8.8%
Q2 25
2.9%
7.2%
Q1 25
4.2%
0.1%
Q4 24
9.6%
-13.5%
Q3 24
10.1%
-12.1%
Q2 24
7.2%
-13.0%
Q1 24
4.0%
-33.4%
EPS (diluted)
HOV
HOV
ONC
ONC
Q4 25
$-0.57
$0.05
Q3 25
$1.99
$0.08
Q2 25
$2.43
$0.06
Q1 25
$3.58
$0.00
Q4 24
$12.47
$-0.10
Q3 24
$9.75
$-0.09
Q2 24
$6.66
$-0.09
Q1 24
$2.91
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HOV
HOV
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$4.5B
Total DebtLower is stronger
$900.7M
$836.4M
Stockholders' EquityBook value
$830.9M
$4.4B
Total Assets
$2.6B
$8.2B
Debt / EquityLower = less leverage
1.08×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HOV
HOV
ONC
ONC
Q4 25
$4.5B
Q3 25
$4.0B
Q2 25
$2.8B
Q1 25
$2.5B
Q4 24
$2.6B
Q3 24
$2.7B
Q2 24
$2.6B
Q1 24
$2.8B
Total Debt
HOV
HOV
ONC
ONC
Q4 25
$900.7M
$836.4M
Q3 25
$861.9M
Q2 25
$864.3M
Q1 25
$893.7M
Q4 24
$896.2M
Q3 24
$898.7M
Q2 24
$933.0M
Q1 24
$934.6M
Stockholders' Equity
HOV
HOV
ONC
ONC
Q4 25
$830.9M
$4.4B
Q3 25
$835.4M
$4.1B
Q2 25
$820.4M
$3.8B
Q1 25
$811.4M
$3.5B
Q4 24
$800.3M
$3.3B
Q3 24
$703.4M
$3.4B
Q2 24
$647.0M
$3.4B
Q1 24
$607.1M
$3.4B
Total Assets
HOV
HOV
ONC
ONC
Q4 25
$2.6B
$8.2B
Q3 25
$2.6B
$7.6B
Q2 25
$2.6B
$6.3B
Q1 25
$2.5B
$5.8B
Q4 24
$2.6B
$5.9B
Q3 24
$2.5B
$5.8B
Q2 24
$2.3B
$5.7B
Q1 24
$2.3B
$5.7B
Debt / Equity
HOV
HOV
ONC
ONC
Q4 25
1.08×
0.19×
Q3 25
1.03×
Q2 25
1.05×
Q1 25
1.10×
Q4 24
1.12×
Q3 24
1.28×
Q2 24
1.44×
Q1 24
1.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HOV
HOV
ONC
ONC
Operating Cash FlowLast quarter
$169.1M
$417.3M
Free Cash FlowOCF − Capex
$164.0M
$379.8M
FCF MarginFCF / Revenue
20.0%
25.4%
Capex IntensityCapex / Revenue
0.6%
2.5%
Cash ConversionOCF / Net Profit
6.28×
TTM Free Cash FlowTrailing 4 quarters
$166.2M
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HOV
HOV
ONC
ONC
Q4 25
$169.1M
$417.3M
Q3 25
$52.8M
$402.6M
Q2 25
$22.3M
$263.6M
Q1 25
$-55.9M
$44.1M
Q4 24
$115.8M
$75.2M
Q3 24
$-92.3M
$188.4M
Q2 24
$89.1M
$-95.6M
Q1 24
$-89.0M
$-308.6M
Free Cash Flow
HOV
HOV
ONC
ONC
Q4 25
$164.0M
$379.8M
Q3 25
$45.8M
$354.5M
Q2 25
$16.0M
$219.8M
Q1 25
$-59.6M
$-12.3M
Q4 24
$111.4M
$-17.3M
Q3 24
$-95.8M
$54.7M
Q2 24
$84.7M
$-205.5M
Q1 24
$-94.4M
$-465.1M
FCF Margin
HOV
HOV
ONC
ONC
Q4 25
20.0%
25.4%
Q3 25
5.7%
25.1%
Q2 25
2.3%
16.7%
Q1 25
-8.8%
-1.1%
Q4 24
11.4%
-1.5%
Q3 24
-13.3%
5.5%
Q2 24
12.0%
-22.1%
Q1 24
-15.9%
-61.9%
Capex Intensity
HOV
HOV
ONC
ONC
Q4 25
0.6%
2.5%
Q3 25
0.9%
3.4%
Q2 25
0.9%
3.3%
Q1 25
0.5%
5.0%
Q4 24
0.5%
8.2%
Q3 24
0.5%
13.3%
Q2 24
0.6%
11.8%
Q1 24
0.9%
20.8%
Cash Conversion
HOV
HOV
ONC
ONC
Q4 25
6.28×
Q3 25
3.18×
3.22×
Q2 25
1.13×
2.79×
Q1 25
-1.98×
34.71×
Q4 24
1.23×
Q3 24
-1.27×
Q2 24
1.75×
Q1 24
-3.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HOV
HOV

Home Building$789.8M97%
Financial Services$28.1M3%
Management Fees$7.1M1%

ONC
ONC

Segment breakdown not available.

Related Comparisons